CTLA4 and neoplasm: As shown in Figure 6B; Supplementary Table 2, treatment with plant-produced anti-CTLA-4 at 3 mg/kg significantly regressed the tumor volume (TGITV = 96.58%) relative to the vehicle group (p < 0.001).